{"id":"https://openalex.org/W4410097542","doi":"https://doi.org/10.1007/s12185-025-03996-0","title":"COVID-19-induced thrombotic microangiopathy in patients with multiple myeloma receiving carfilzomib treatment","display_name":"COVID-19-induced thrombotic microangiopathy in patients with multiple myeloma receiving carfilzomib treatment","publication_year":2025,"publication_date":"2025-05-05","ids":{"openalex":"https://openalex.org/W4410097542","doi":"https://doi.org/10.1007/s12185-025-03996-0","pmid":"https://pubmed.ncbi.nlm.nih.gov/40323572"},"language":"en","primary_location":{"id":"doi:10.1007/s12185-025-03996-0","doi":"https://doi.org/10.1007/s12185-025-03996-0","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12185-025-03996-0","pdf_url":null,"source":{"id":"https://openalex.org/S45192162","display_name":"International Journal of Hematology","issn_l":"0925-5710","issn":["0925-5710","1865-3774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Kaito Takikawa","orcid":"https://orcid.org/0009-0000-4957-9058","observed_orcids":["https://orcid.org/0009-0000-4957-9058"]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kaito Takikawa","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan. kaitakikawa@keio.jp"],"raw_orcid":"https://orcid.org/0009-0000-4957-9058","affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan. kaitakikawa@keio.jp","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mana Sota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mana Sota","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029412107","display_name":"Shiori Nakashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shiori Nakashima","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090114967","display_name":"Yui Imai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yui Imai","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018610678","display_name":"Hirofumi Nakano","orcid":"https://orcid.org/0000-0002-0798-2321","observed_orcids":["https://orcid.org/0000-0002-0798-2321"]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirofumi Nakano","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100541710","display_name":"Tomoyuki Uchida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoyuki Uchida","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103719792","display_name":"Morihiro Inoue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Morihiro Inoue","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028277227","display_name":"Masao Hagihara","orcid":"https://orcid.org/0000-0002-7143-4813","observed_orcids":["https://orcid.org/0000-0002-7143-4813"]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masao Hagihara","raw_affiliation_strings":["Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Eiju General Hospital, 2-23-16 Higashiueno, Taito-ku, Tokyo, 110-8645, Japan","institution_ids":["https://openalex.org/I4210107860"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089020040","display_name":"Akiko Torii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107860","display_name":"Eiju General Hospital","ror":"https://ror.org/01vk45p32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107860"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akiko Torii","raw_affiliation_strings":["Department of Nephrology, Eiju General Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Eiju General Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210107860"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210107860"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.3003,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.44539386,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"122","issue":"3","first_page":"449","last_page":"453"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8790000081062317},{"id":"https://openalex.org/keywords/thrombotic-microangiopathy","display_name":"thrombotic microangiopathy","score":0.9269999861717224},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":1.0},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8730000257492065},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.9309999942779541},{"id":"https://openalex.org/keywords/endothelial-injury","display_name":"endothelial injury","score":0.8970000147819519},{"id":"https://openalex.org/keywords/therapeutic-plasma-exchange","display_name":"plasma exchange","score":0.9020000100135803},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.8420000076293945},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.8009999990463257},{"id":"https://openalex.org/keywords/booster-vaccination","display_name":"booster vaccination","score":0.7730000019073486},{"id":"https://openalex.org/keywords/relapsed-multiple-myeloma","display_name":"relapsed multiple myeloma","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.963455080986023},{"id":"https://openalex.org/C2777878052","wikidata":"https://www.wikidata.org/wiki/Q3312044","display_name":"Thrombotic microangiopathy","level":3,"score":0.8487955331802368},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7631704807281494},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.7362918853759766},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7238022089004517},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.661928653717041},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6050547361373901},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5088803768157959},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43016114830970764},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.42610305547714233},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3512989282608032},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.2663634419441223},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010951","descriptor_name":"Plasma Exchange","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057049","descriptor_name":"Thrombotic Microangiopathies","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D057049","descriptor_name":"Thrombotic Microangiopathies","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D057049","descriptor_name":"Thrombotic Microangiopathies","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12185-025-03996-0","doi":"https://doi.org/10.1007/s12185-025-03996-0","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12185-025-03996-0","pdf_url":null,"source":{"id":"https://openalex.org/S45192162","display_name":"International Journal of Hematology","issn_l":"0925-5710","issn":["0925-5710","1865-3774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:40323572","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40323572","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of hematology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W2028031291","https://openalex.org/W2081359434","https://openalex.org/W2565152113","https://openalex.org/W2805630869","https://openalex.org/W2952822323","https://openalex.org/W3031484162","https://openalex.org/W3092819537","https://openalex.org/W3115695623","https://openalex.org/W3119605648","https://openalex.org/W3129593041","https://openalex.org/W3133504941","https://openalex.org/W3153080283","https://openalex.org/W3193050151","https://openalex.org/W3214284312","https://openalex.org/W3217424271","https://openalex.org/W4221101837","https://openalex.org/W4226461640","https://openalex.org/W4291209041","https://openalex.org/W4297057011","https://openalex.org/W4297785714","https://openalex.org/W4310957849","https://openalex.org/W4317624072","https://openalex.org/W4383999137","https://openalex.org/W4385273593","https://openalex.org/W4387779908","https://openalex.org/W4387876150","https://openalex.org/W4391228175","https://openalex.org/W4391848394","https://openalex.org/W6607991529","https://openalex.org/W6794431852"],"related_works":["https://openalex.org/W4293553591","https://openalex.org/W4404597743","https://openalex.org/W4381164863","https://openalex.org/W3122220390","https://openalex.org/W4396785541","https://openalex.org/W3157520780","https://openalex.org/W4367600334","https://openalex.org/W2979763684","https://openalex.org/W4297236122","https://openalex.org/W2298050501"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-05-06T00:00:00"}